|
S. No. | Element | Complexes | Antimicrobial activity | Mode of action | References |
|
s-block elements |
1 | Lithium (Li) | LiC6H7O6 | Lithium complexes are a good source of antioxidant | Increases the GABA level which in turn reduces glutamate and downregulates the NMDA receptors | [87] |
2 | C4H6LiNO4 | Lithium complexes are a good source of antioxidant | Increases the GABA level which in turn reduces glutamate and downregulates the NMDA receptors | [87] |
3 | Li2CO3 | Lithium complexes are a good source of antioxidant | Increases the GABA level which in turn reduces glutamate and downregulates the NMDA receptors | [87] |
4 | Calcium (Ca) | Ca (Cur)2 | P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus | Membrane disruption by inhibiting ATPase activity | [88] |
p-block elements |
5 | Gallium (Ga) | [GaCl2 (4- MepzH)4] GaCl4 | Effective against HIV | Fe metabolism | [84] |
6 | Tin (Sn) | Sn (Cur)2 | Have antifungal potential against P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus | Membrane disruption by inhibiting ATPase activity | [88] |
7 | Lead (Pb) | Pb (Cur)2 | Have antifungal potential against P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus | Membrane disruption by inhibiting ATPase activity | [88] |
d-block elements |
8 | Cromium (Cr) | Cr (Curc)3 | Shows antibacterial activity against E. coli, K. pneumonia, and Pseudomonas sp. | Membrane disruption by inhibiting ATPase activity | [88] |
9 | npapCr | Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum. Also have antiviral potential against TMV and HSV. | Cytotoxicity | [89] |
10 | Manganese (Mn) | [MnL] Cl2 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhances the penetration of the complexes into lipid membranes | [90] |
11 | Iron (Fe) | FeCur (OH)2 | E. coli is the bacterial against which iron complex act | Membrane disruption by inhibiting ATPase activity | [88] |
12 | C18H19ClN3.C5H5.Fe | Antibacterial against plasmodium falciparum | Active against chloroquine-resistant parasitic strains by producing ROS β-lactamase | [89] |
13 | npapFe | Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum and also have antiviral potential against TMV and HSV. | Cytotoxicity | [89] |
14 | [Fe (sulfamethoxazole)2 Cl2].2H2O | Antibacterial activity against S. aureus, B. subtilis, P. aeruginosa, K. pneumonia, and E. coli | Cytotoxicity | [43] |
15 | Cobalt (Co) | [CoCurCl] Cl | Penicillium digitatum fungi and bacteria such as Streptococcus pyogenes, S. aureus, and A. flavus against which antimicrobial activity is reported | Chain breakage | [88] |
16 | CoCurCl | S. aureus, B. subtilis, S. typhi, and E. coli are the bacteria against which cobalt complexes act. | Membrane disruption by inhibiting ATP-ase activity | [88] |
17 | [CoL] Cl2 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola are reported | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes | [89] |
18 | Co (sulfamethoxazole)2.3H2O | Possess antibacterial activity against Mycobacterium tuberculosis | Cytotoxicity | [43] |
19 | npapCo | Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum and also have antiviral potential against TMV and HSV. | Cytotoxicity | [89] |
20 | Nickel (Ni) | [NiCurCl] Cl | Penicillium digitatum, fungi, and bacteria such as Streptococcus pyogenes, S. aureus, and A. flavus against which antimicrobial activity is reported | Membrane disruption by inhibiting ATPase activity | [88] |
21 | NiCurCl | S. aureus, B. subtilis, S. typhi, P. aeruginosa, and E. coli are the bacteria affected by nickel complexes | | [88] |
22 | npapNi | Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum and also have antiviral potential against TMV and HSV. | Cytotoxicity | [89] |
23 | Ni (sulfamethoxazole)2 Cl].2H2O | Antibacterial activity against P. aeruginosa, Klebsiella pneumonia, B. subtilis, E. coli, and S. aureus | Cytotoxicity | [43] |
24 | [NiL] Cl2 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and B. subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhances the penetration of the complexes into lipid membranes | [89] |
25 | Copper (Cu) | [CuCl (H2itsc) (Ph3P)2] 2CH3CN | Possess antiviral activity and antitumor activity | Cell death | [91] |
26 | C32H16CuN8 | S. enterica and P. aeruginosa bacteria for which antimicrobial activity was reported | DNA intercalation | [92] |
27 | [Cu (sulfisoxazole)2 (H2O)4] ·2H2O | E. coli and S. aureus bacteria for which antimicrobial activity was reported | Inhibiting folic acid synthesis | [88] |
28 | [CuCurCl] Cl | Penicillium digitatum, fungi, and bacteria such as Streptococcus pyogenes, S. aureus and A. flavus against which antimicrobial activity is reported | Membrane disruption by inhibiting ATPase activity | [88] |
29 | Cu (Cur)2 | S. aureus, E. coli, Klebsiella pneumonia, and Pseudomonas fluorescence | Membrane disruption by inhibiting ATPase activity | [88] |
30 | CuCurCl | S. typhi, P. aeruginosa, and E. coli are effected by copper complexes | Membrane disruption by inhibiting ATPase activity | [88] |
31 | C32H16CuN8 | Antibacterial activity shown against S. enteric and P. aeruginosa | DNA intercalation | [92] |
32 | [CuL] Cl2 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes | [93] |
33 | Cu (sulfisoxazole)2 H2O | Antibacterial against S. aureus and E. coli | Cytotoxicity | [43] |
34 | Cu (sulfisoxazole)2 (H2O)2.3H2O | Antibacterial activity against S. aureus and E. coli | Cytotoxicity | [43] |
35 | Zinc (Zn) | [ZnCurCl] Cl | Penicillium digitatum, fungi, and bacteria such as Streptococcus pyogenes, S. aureus, and A. flavus against antimicrobial activity | Membrane disruption by inhibiting ATPase activity | [88] |
36 | [ZnL] Cl2 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataicola | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes | [94] |
37 | Ruthenium (Ru) | [Ru (Me4phen)3]2 | Active against Gram-positive bacteria and Mycobacterium tuberculosis | Lipophilicity, charge, and charge separation conducted by Ru | [72] |
38 | [Ru (Me4phen)2 (acac)]+ | Active against Gram-positive bacteria and Mycobacterium tuberculosis | Lipophilicity, charge, and charge separation conducted by Ru | [72] |
39 | [Ru (2,9-Me2phen)2 (dppz)]2+ | Active against S. aureus | Lipophilicity, charge, and charge separation conducted by Ru | [72] |
40 | [Ru (dmob)3]2+ | Active against S. aureus | Lipophilicity, charge, and charge separation conducted by Ru | [72] |
41 | ([ru (X-phen)2 (acac)]+1 | Antibacterial activity against Corynebacterium diphtheriae, Mycobacterium tuberculosis, and Staphylococcus aureus | Growth inhibition by disturbing biological processes | [35] |
42 | Palladium (Pd) | Pd (Curc)2 | E. coli and K. pneumonia are the bacteria against which palladium act | Membrane disruption by inhibiting ATPase activity | [88] |
43 | Silver (Ag) | [HB (3,5- (CF3) 2pz)3] Ag (OSMe2)] | Have ability against Staphylococcus aureus | Cytotoxicity | [88] |
44 | Ag (I) carbene | Antibiotic for E. coli, S. aureus, and P. aeruginosa | Eat up bacteria | [92] |
45 | Ag (I)–saccharin complex | Antimicrobial activity against Gram + ve bacteria (Micrococcus luteus and S. aureus) and Gram-negative bacteria (E. coli and, Proteus vulgaris, and P. aeruginosa) | Eat up bacteria | [95] |
46 | Ag (I)-cyclamate | Antibacterial activity against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium malmoense, and Mycobacterium kansasii. | Eat up bacteria | [96] |
47 | Ag (I)-aspartame | Antibacterial activity against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium malmoense, and Mycobacterium kansasii. | Eat up bacteria | [96] |
48 | [HB (3,5-(CF3) 2pz) 3] Ag (thf)] | Have ability against Staphylococcus aureus | Cytotoxicity | [24, 97] |
49 | AgNO3 | Effective against Ophthalmia neonatorum | Binding of free silver ions with tissue proteins, which leads to their precipitation and the obstruction of small vessels | [24] |
50 | C10H9AgN4O2S | Antibacterial activity against Salmonella, E. coli, and S. aureus | Cytotoxicity | [43] |
51 | Cadmium (Cd) | Cd (Cur)2 | Penicillium verruculosum, Aspergillus niger, Aspergillus heteromorphus, Aspergillus flavus, and B. cereus | Membrane disruption by inhibiting ATPase activity | [88] |
52 | (CdL) Cl2 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataicola | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhances the penetration of the complexes into lipid membranes | [98] |
53 | Mercury (Hg) | Hg (Cur)2 | P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus | Membrane disruption by inhibiting ATPase activity | [88] |
54 | (HgL) Cl2 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes | [99] |
55 | Vanadium (V) | [VOL] SO4 | Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola | Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes | [1] |
|